ArticleCancers2026

Effects of Combining Immune-Priming Sub-Lethal Low-Dose Radiation with 4-1BB Activation and Gal-3 Blockade in In Vitro and Preclinical Group-3 Medulloblastoma Models.

Arabinda Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.